Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing

Expert Opinion on Investigational Drugs

Volumn 18, Issue 11, 2009, Pages 1633-1654

  Graham, Simon ^a   Leonidou, Andreas ^a   Lester, Marie ^a   Heliotis, Manolis ^b   Mantalaris, Athanasios ^b   Tsiridis, Eleftherios ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Fracture healing; Osteoporosis; Platelet derived growth factor

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

BONE DENSITY; BONE METABOLISM; DATA BASE; EVIDENCE BASED PRACTICE; FRACTURE HEALING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDICAL RESEARCH; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPOROSIS; REVIEW; SEARCH ENGINE; SYSTEMATIC REVIEW;

ANIMALS; BONE DENSITY; DRUG DELIVERY SYSTEMS; FRACTURE HEALING; HUMANS; OSTEOGENESIS; OSTEOPOROSIS; PLATELET-DERIVED GROWTH FACTOR;

EID: 73849120770     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543780903241607     Document Type: Review

References (76)

1. Claesson-Welsh L, Heldin CH. Platelet-derived growth factor. Three isoforms that bind to two distinct cell surface receptors. Acta Oncol 1989;28(3):331-334
2. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999;79(4):1283-1316
3. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008;22(10):1276-1312
4. Andrew JG, Hoyland JA, Freemont AJ, Marsh DR. Platelet-derived growth factor expression in normally healing human fractures. Bone 1995;16(4):455-460
5. McCarthy HS, Williams JH, Davie MW, Marshall MJ. Platelet-derived growth factor stimulates osteoprotegerin production in osteoblastic cells. J Cell Physiol 2009;218(2):350-354
6. Zhang L, Leeman E, Carnes DC, Graves DT. Human osteoblasts synthesize and respond to platelet-derived growth factor. Am J Physiol 1991;261(2 Pt 1):C348-54
7. Zhang Z, Chen J, Jin D. Platelet-derived growth factor (PDGF)-BB stimulates osteoclastic bone resorption directly: the role of receptor beta. Biochem Biophys Res Commun 1998;251(1):190-194
8. Howell TH, Fiorellini JP, Paquette DW, et al. A phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997;68(12):1186-1193
9. Nevins M, Giannobile WV, McGuire MK, et al. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol 2005;76(12):2205-2215
10. Heldin CH, Eriksson U, Ostman A. New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys 2002;398(2):284-290
11. Horner A, Bord S, Kemp P, et al. Distribution of platelet-derived growth factor (PDGF) A chain mRNA, protein, and PDGF-alpha receptor in rapidly forming human bone. Bone 1996;19(4):353-362
12. Fujii H, Kitazawa R, Maeda S, et al. Expression of platelet-derived growth factor proteins and their receptor alpha and beta mRNAs during fracture healing in the normal mouse. Histochem Cell Biol 1999;112(2):131-138
13. Barnes GL, Kostenuik PJ, Gerstenfeld LC, Einhorn TA. Growth factor regulation of fracture repair. J Bone Miner Res 1999;14(11):1805-1815
14. Soriano P. The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. Development 1997;124(14):2691-2700
15. Mannaioni PF, Di Bello MG, Masini E. Platelets and inflammation: role of platelet-derived growth factor, adhesion molecules and histamine. Inflamm Res 1997;46(1):4-18
16. Slater M, Patava J, Kingham K, Mason RS. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 1995;13(5):655-663
17. Tanaka H, Liang CT. Effect of platelet-derived growth factor on DNA synthesis and gene expression in bone marrow stromal cells derived from adult and old rats. J Cell Physiol 1995;164(2):367-375
18. Pfeilschifter J, Oechsner M, Naumann A, et al. Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta. Endocrinology 1990;127(1):69-75
19. Tsukamoto T, Matsui T, Fukase M, Fujita T. Platelet-derived growth factor B chain homodimer enhances chemotaxis and DNA synthesis in normal osteoblast-like cells (MC3T3-E1). Biochem Biophys Res Commun 1991;175(3):745-751
20. Centrella M, McCarthy TL, Kusmik WF, Canalis E. Relative binding and biochemical effects of heterodimeric and homodimeric isoforms of platelet-derived growth factor in osteoblast-enriched cultures from fetal rat bone. J Cell Physiol 1991;47(3):420-426
21. Canalis E, McCarthy TL, Centrella M. Effects of platelet-derived growth factor on bone formation in vitro. J Cell Physiol 1989;140(3):530-537
22. Canalis E. Effect of platelet-derived growth factor on DNA and protein synthesis in cultured rat calvaria. Metabolism 1981;30(10):970-975
23. Herbertson A, Aubin JE. Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures. J Bone Miner Res 1995;10(2):285-294
24. Tokunaga A, Oya T, Ishii Y, et al. PDGF receptor beta is a potent regulator of mesenchymal stromal cell function. J Bone Miner Res 2008;23(9):1519-1528
25. Hock JM, Canalis E. Platelet-derived growth factor enhances bone cell replication, but not differentiated function of osteoblasts. Endocrinology 1994;134(3):1423-1428
26. Canalis E, Pash J, Gabbitas B, et al. Growth factors regulate the synthesis of insulin-like growth factor-I in bone cell cultures. Endocrinology 1993;133(1):33-38
27. Kim HD, Valentini RF. Human osteoblast response in vitro to platelet-derived growth factor and transforming growth factor-beta delivered from controlled-release polymer rods. Biomaterials 1997;18(17):1175-1184
28. Bateman J, Intini G, Margarone J, et al. Platelet-derived growth factor enhancement of two alloplastic bone matrices. J Periodontol 2005;76(11):1833- 1841
29. Intini G, Andreana S, Margarone JE III, et al. Engineering a bioactive matrix by modifications of calcium sulfate. Tissue Eng 2002;8(6):997-1008
30. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-147
31. Fiedler J, Roderer G, Gunther KP, Brenner RE. BMP-2, BMP-4, and PDGF-bb stimulate chemotactic migration of primary human mesenchymal progenitor cells. J Cell Biochem 2002;87(3):305-312
32. Yang D, Chen J, Jing Z, Jin D. Platelet-derived growth factor (PDGF)-AA: a self-imposed cytokine in the proliferation of human fetal osteoblasts. Cytokine 2000;12(8):1271-1274
33. Chaudhary LR, Hofmeister AM, Hruska KA. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 2004;34(3):402-411
34. Jilka RL, Hangoc G, Girasole G, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992;257(5066):88-91
35. Franchimont N, Durant D, Rydziel S, Canalis E. Platelet-derived growth factor induces interleukin-6 transcription in osteoblasts through the activator protein-1 complex and activating transcription factor-2. J Biol Chem 1999;274(10):6783-6789
36. van den Dolder J, Mooren R, Vloon AP, et al. Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. Tissue Eng 2006;12(11):3067-3073
37. Lucarelli E, Beccheroni A, Donati D, et al. Platelet-derived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003;24(18):3095-3100
38. Gruber R, Karreth F, Kandler B, et al. Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions. Platelets 2004;15(1):29-35
39. Arpornmaeklong P, Kochel M, Depprich R, et al. Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study. Int J Oral Maxillofac Surg 2004;33(1):60-70
40. Gruber R, Karreth F, Frommlet F, et al. Platelets are mitogenic for periosteum-derived cells. J Orthop Res 2003;21(5):941-948
41. Humphrey EL, Williams JH, Davie MW, Marshall MJ. Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells. Bone 2006;38(5):652-661
42. Quinn JM, Horwood NJ, Elliott J, et al. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 2000;15(8):1459-1466
43. Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med 2001;79(5-6):243-253
44. Cross SS, Yang Z, Brown NJ, et al. Osteoprotegerin (OPG)-a potential new role in the regulation of endothelial cell phenotype and tumour angiogenesis? Int J Cancer 2006;118(8):1901-1908
45. Tokuda H, Takai S, Hanai Y, et al. Potentiation by platelet-derived growth factor-BB of FGF-2-stimulated VEGF release in osteoblasts. J Bone Miner Metab 2008;26(4):335-341
46. Nicosia RF, Nicosia SV, Smith M. Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 1994;145(5):1023-1029
47. Wilson RJ, Rhodes SA, Wood RL, et al. Functional pharmacology of human prostanoid EP2 and EP4 receptors. Eur J Pharmacol 2004;501(1-3):49-58
48. Ke HZ, Shen VW, Qi H, et al. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia. Bone 1998;23(3):249-255
49. Li XJ, Jee WS, Li YL, Patterson-Buckendahl P. Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs. Bone 1990;11(5):353-364
50. Dekel S, Lenthall G, Francis MJ. Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits. J Bone Joint Surg Br 1981;63-B(2):185-189
51. Keller J, Bunger C, Andreassen TT, et al. Bone repair inhibited by indomethacin. Effects on bone metabolism and strength of rabbit osteotomies. Acta Orthop Scand 1987;58(4):379-383
52. Voegeli TL, Chapman MW. Utilization of prostaglandin in fracture healing. Trans Orthop Res Soc 1985;10:134 [abstract]
53. Chen QR, Miyaura C, Higashi S, et al. Activation of cytosolic phospholipase A2 by platelet-derived growth factor is essential for cyclooxygenase-2-dependent prostaglandin E2 synthesis in mouse osteoblasts cultured with interleukin-1. J Biol Chem 1997;272(9):5952-5958
54. Rasubala L, Yoshikawa H, Nagata K, et al. Platelet-derived growth factor and bone morphogenetic protein in the healing of mandibular fractures in rats. Br J Oral Maxillofac Surg 2003;41(3):173-178
55. Tyndall WA, Beam HA, Zarro C, et al. Decreased platelet derived growth factor expression during fracture healing in diabetic animals. Clin Orthop Relat Res 2003;408:319-330
56. Tanaka H, Wakisaka A, Ogasa H, et al. Effect of IGF-I and PDGF administered in vivo on the expression of osteoblast-related genes in old rats. J Endocrinol 2002;174(1):63-70
57. Street JT, Wang JH, Wu QD, et al. The angiogenic response to skeletal injury is preserved in the elderly. J Orthop Res 2001;19(6):1057-1066
58. Nash TJ, Howlett CR, Martin C, et al. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 1994;15(2):203-208
59. Arm DM, Tencer AF, Bain SD, Celino D. Effect of controlled release of platelet-derived growth factor from a porous hydroxyapatite implant on bone ingrowth. Biomaterials 1996;17(7):703-709
60. Lynch SE, de Castilla GR, Williams RC, et al. The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol 1991;62(7):458-467
61. Simion M, Rocchietta I, Kim D, et al. Vertical ridge augmentation by means of deproteinized bovine bone block and recombinant human platelet-derived growth factor-BB: a histologic study in a dog model. Int J Periodontics Restorative Dent 2006;26(5):415-423
62. Hollinger JO, Onikepe AO, MacKrell J, et al. Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res 2008;26(1):83-90
63. Mitlak BH, Finkelman RD, Hill EL, et al. The effect of systemically administered PDGF-BB on the rodent skeleton.J Bone Miner Res 1996;11(2):238-247
64. Macey LR, Kana SM, Jingushi S, et al. Defects of early fracture-healing in experimental diabetes. J Bone Joint Surg Am 1989;71(5):722-733
65. Verhaeghe J, van Herck E, Visser WJ, et al. Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes 1990;39(4):477-482
66. Kagel EM, Einhorn TA. Alterations of fracture healing in the diabetic condition. Iowa Orthop J 1996;16:147-152
67. Loder RT. The influence of diabetes mellitus on the healing of closed fractures. Clin Orthop Relat Res 1988;232:210-216
68. Ranly DM, McMillan J, Keller T, et al. Platelet-derived growth factor inhibits demineralized bone matrix-induced intramuscular cartilage and bone formation. A study of immunocompromised mice. J Bone Joint Surg Am 2005;87(9):2052-2064
69. Roussy Y, Bertrand Duchesne MP, Gagnon G. Activation of human platelet-rich plasmas: effect on growth factors release, cell division and in vivo bone formation. Clin Oral Implants Res 2007;18(5):639-648
70. Libin BM, Ward HL, Fishman L. Decalcified, lyophilized bone allografts for use in human periodontal defects. J Periodontol 1975;46(1):51-56
71. Sarment DP, Cooke JW, Miller SE, et al. Effect of rhPDGF-BB on bone turnover during periodontal repair. J Clin Periodontol 2006;33(2):135-140
72. McGuire MK, Kao RT, Nevins M, Lynch SE. rhPDGF-BB promotes healing of periodontal defects: 24-month clinical and radiographic observations. Int J Periodontics Restorative Dent 2006;26(3):223-231
73. Eastell R, Robins SP, Colwell T, et al. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporos Int 1993;3(5):255-260
74. Giannobile WV, Lynch SE, Denmark RG, et al. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. A pilot study in beagle dogs. J Clin Periodontol 1995;22(12):903-910
75. Sharp JD, White DL, Chiou XG, et al. Molecular cloning and expression of human Ca(2+)-sensitive cytosolic phospholipase A2. J Biol Chem 1991;266(23):14850-14853
76. Hollinger JO, Hart CE, Hirsch SN, et al. Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am 2008;90(Suppl 1):48-54